STOPAIDS Welcomes Unitaid’s Landmark Pricing Agreement to Expand Affordable Access to Long-Acting...
Statement from Mike Podmore, CEO, STOPAIDS, in response to this week’s announcement from Unitaid that HIV prevention tool, injectable lenacapavir, will be available at a cost of US$40 a year in 120...
stopaids.org.uk